This is a draft of an article published in the Times in  February 2005 [Unable to find it online] It was written shortly after the anti-inflammatory drug Vioxx had been withdrawn because it raised the risk of heart disease. After its withdrawal it became clear that the company had gone to extraordinary lengths to conceal the […]